Clinical Trial Update: ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS) [Phase 2]

View source ↗

Summary

Phase 2 trial of antibody-level analysis for convalescent serum in COVID-19 patients was terminated; results posted previously.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infections

Snippet

Sponsor: Corewell Health East | Conditions: COVID-19, Severe Acute Respiratory Syndrome (SARS) | Phase 2 | Status: TERMINATED | Results posted: 2021-11-22